Ken Beckman, MD, FACS, is a corneal specialist and clinical assistant professor at The Ohio State University. At the 2025 ...

A study published in JAMA Ophthalmology on Thursday suggests that "pickleball-related eye injuries have increased at an ...

In the Phase 2 TEASE 2 trial, gildeuretinol was well tolerated and showed promising trends in slowing ellipsoid zone loss and preserving low-luminance visual acuity in patients with Stargardt disease.

They say that a picture is worth a thousand words. But images are also dense with data and that is why ophthalmology is the vanguard of specialties using artificial intelligence (AI), explains Alfredo ...

The need for enhancement procedures after SMILE is rare, but surgeons need to consider the advantages and disadvantages of ...

Dehydrated corneas were noninferior to standard donor corneas for deep anterior lamellar keratoplasty, according to a ...

NYU Langone Health ophthalmology faculty present their latest research at this year's annual meeting of the American Academy ...

FDA agrees with Phase 2b/3 clinical design, including primary endpoint and development approach, providing clear regulatory ...

At the American Academy of Ophthalmology meeting, Andrew G. Lee, M.D., explained that El Niño and La Niña weather patterns—worsened by climate change—can worsen eye conditions such as dry eye, ...

Researchers have received a $2.2 million grant from the National Institute on Aging of the National Institutes of Health to ...

We are excited that these results will be presented in a late-breaking oral presentation at AAO 2025, which is the largest meeting of ophthalmologists in the U.S.,” stated Nikhil Lalwani, President ...